Cases and resources in vascular techniques

A young woman with neurofibromatosis type 1 and severe hypertension despite four antihypertensive drugs presented with a complex renal artery aneurysm. The aneurysm was relatively small, raising an important question: was its size really the main factor driving the decision to treat?

In the second part of this conversation, Dr Alexandros Mallios and Dr William Jennings discuss complex surgical dialysis access strategies, including basilic and brachial vein transpositions, graft selection, perforator vein preparation and technical considerations for successful AVF creation. They also explore the evolution of the "Fistula First" philosophy and the ongoing debate between fistulas and grafts.

Two PVI 2025 studies, two perspectives on DCB therapy: Prof. Bibombe Patrice Mwipatayi discusses long-term outcomes in CLTI and the pharmacokinetic profile and clinical results of a novel limus-derivative DCB.

At 3 years, LIFE-BTK showed sustained efficacy of the resorbable scaffold over PTA, with lower restenosis and comparable safety and limb salvage. The benefit persisted beyond scaffold resorption, although the difference narrowed over time.

A 75-mm saccular juxtarenal aneurysm had rapidly expanded in a patient with weight loss and an inflammatory response. What treatment strategy would you choose in this challenging setting?

In this episode, Dr Alexandros Mallios speaks with Dr William Jennings about the principles guiding surgical arteriovenous fistula creation. From vessel assessment and ultrasound mapping to proximal radial artery fistulas and evolving surgical strategies, the discussion explores the clinical reasoning behind choosing the right access for each patient.

Dr Ruiz Chiriboga and Dr Leal Lorenzo explore what CREST-2 could mean for the management of asymptomatic carotid disease, while discussing new-generation stents, flow reversal and the importance of measuring individual outcomes.

How much has the haemodialysis catheter really evolved? Prof. Maurizio Gallieni and Dr Edoardo Pasqui discuss persistent challenges in vascular access, from infection and thrombosis to central venous injury, and explore where innovation is still needed to improve long-term patient outcomes.

Dr Tara Mastracci discusses the evolution of complex aortic surgery with Dr Marta Lobato, exploring clinical decision-making, aortic dissection, emerging technologies and the impact of social deprivation on patient outcomes. She also reflects on her journey as a woman in vascular surgery, the importance of leadership and mentorship, and what the next generation of aortic surgeons can expect from the field.

The TRACK trial found that low-dose rivaroxaban did not reduce cardiovascular events in advanced CKD, but significantly increased major bleeding.